26Al Tracer Experiment by Accelerator Mass Spectrometry and its Application to the Studies for Amyotrophic Lateral Sclerosis and Alzheimer's Disease. I.

Koichi KOBAYASHI; Sakae YUMOTO; Hisao NAGAI; Yoshiyuki HOSOYAMA; Mineo IMAMURA; Shin-ichirou MASUZAWA; Yoshinobu KOIZUMI; Hiroshi YAMASHITA

doi:10.2183/pjab.66.189

²⁶Al Tracer Experiment by Accelerator Mass Spectrometry and its Application to the Studies for Amyotrophic Lateral Sclerosis and Alzheimer's Disease. I.

Koichi KOBAYASHI, Sakae YUMOTO, Hisao NAGAI, Yoshiyuki HOSOYAMA, Mineo IMAMURA, Shin-ichirou MASUZAWA, Yoshinobu KOIZUMI, Hiroshi YAMASHITA

Author information

Keywords: Accelerator mass spectrometry, amyotrophic lateral sclerosis, Alzheimer's disease, ²⁶Al tracer, aluminum toxicity

JOURNAL FREE ACCESS

1990 Volume 66 Issue 10 Pages 189-192

DOI https://doi.org/10.2183/pjab.66.189

Details

Abstract

Accelerator mass spectrometry (AMS) was applied for ²⁶Al tracer experiment to study the aluminum toxicity and metabolism in rats. To investigate the cause of amyotrophic lateral sclerosis (ALS) and Alzheimer's disease, the aluminum incorporation into the brain (cerebrum) was studied by AMS using ²⁶Al as a tracer. When ²⁶Al was intraperitoneally injected into rats, a considerable amount of ²⁶Al was incorporated into the cerebrum after 5-35 days of the injection.

Corresponding author